10x Genomics
TXG
$26.64
Share price
-3.20%
Change (1 day)
-50.91%
Change (1 year)
Categories
10x Genomics (TXG) - Cash on Hand
Cash on Hand as of December 2023 : $0.38 B
According to 10x Genomics
's latest financial reports the company has $0.38 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
10x Genomics - Cash on Hand chart (from 2018 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.38 B | -9.6% |
| 2022-12-31 | $0.42 B | -26.8% |
| 2021-12-31 | $0.58 B | -11.48% |
| 2020-12-31 | $0.66 B | 56.45% |
| 2019-12-31 | $0.42 B | 551.76% |
| 2018-12-31 | $65.08 M | 35.99% |
| 2017-12-31 | $47.85 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $5.29 M | -98.64% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $0.12 B | -67.73% | 🇬🇧 UK |
 Novavax NVAX | $0.56 B | 46.26% | 🇺🇸 USA |
 Novocure
NVCR | $0.91 B | 134.28% | Jersey |